Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. (Q34019169)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. |
scientific article |
Statements
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer (English)
Suresh S Ramalingam
Madhusmita Behera
Janakiraman Subramanian
Nabil F Saba
Scott A Kono
Anthony A Gal
Gabriel Sica
R Donald Harvey
Zhengjia Chen
Carmen M Klass
Dong M Shin
Haian Fu
Shi-yong R Sun
Ramaswamy Govindan